JAROSLAW KIERKUS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab (NCT06614387) | JAROSLAW KIERKUS | 2024-10-01 |
Track JAROSLAW KIERKUS automatically
Every clearance here is in the API, with alerts when new ones post.